China-based MicroPort Scientific Corp (HKG: 0853), a leading medical device company, announced that its spin-off, MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), has secured the CE mark for its VitaFlow Liberty transcatheter aortic valve and its recyclable delivery system. This regulatory approval paves the way for the product’s market entry in Europe.
VitaFlow Liberty, the second-generation transcatheter aortic valve implantation (TAVI) product from CardioFlow, has already been implemented in nearly 600 hospitals across China. Additionally, it has been used in approximately 100 hospitals in Argentina, Colombia, Thailand, Russia, and Indonesia, indicating a broad international reach.- Flcube.com
